+ General Considerations
- 2nd most common skin tumor (8% in Great Britain and 20% in USA)
- Feline mast cells also contain surface-bound immunoglobulins capable of secreting histamine, heparin, and other vasoactive compounds
- Feline mast cells also have phagocytic capability and can endocytose erythrocytes
- Degranulation can cause coagulation disorders, GI ulceration, and anaphylactoid reactions
CUTANEOUS MAST CELL TUMOR
+ General Considerations
- 2 types: Mastocytic (similar to dog and more common) and Histiocytic (less common)
- Edema, eosinophilia, and collagen denaturation associated with canine MCT are not seen in feline MCT
- 50% of cats with cutaneous MCT have tumors develop in other sites within weeks to months after surgery
+ Mastocytic Mast Cell Tumor
- Mean age:10 years
- No sex or breed predilection, but Siamese cats are over-represented in some reports
- Cutaneous MCT are often malignant (44%-59%) and associated with multiple cutaneous or visceral involvement
- Feline MCT are usually solitary (< 1 cm diameter), firm, and raised with superficial ulceration in 25%
- 20% multiple
- Sites:45% of cutaneous MCT found on head and 21% on limbs
- 2 clinical forms: flat pruritic plaque-like lesion and discrete subcutaneous nodule
- Feline cutaneous MCT is subdivided into compact and diffuse forms which may have prognostic significance
- Histologic grading system used in dogs does not have prognostic value in cats
+ Compact Mastocytic Mast Cell Tumors
- Compact MCT accounts for 50%-90% cases and most are benign
- Compact MCT: homogenous cords and nests of slightly atypical mast cells with basophilic round nuclei, ample eosinophilic cytoplasm, and distinct cell borders, with 50% eosinophils
+ Diffuse Mastocytic Mast Cell Tumors
- Diffuse MCT are more anaplastic and many are malignant with presenting signs of generalized, pruritic, and miliary lesions combined with alopecia, erythema, excoriations, and diffuse lichenification
- Diffuse MCT: less discrete and infiltrates into the subcutaneous tissue, larger nuclei > 50% of cell size, 2-3 mitotic figures per HPF, marked anisocytosis with mononuclear and multinucleated giant cells, and eosinophils are common
+ Histiocytic Mast Cell Tumor
- Mean age:2.4 years
- Sex predisposition: ± male
- Breed predilection: ± Siamese
- Spontaneously regressing multicentric histiocytic form of MCT in Siamese < 4 years
- Spontaneous regression occurs over 4-24 months
- Diagnosis: histology with histiocyte-like cells with equivocal cytoplasmic granularity, randomly scattered lymphoid aggregates, and eosinophils
- DDx: granulomatous nodular panniculitis or deep dermatitis
+ Prognosis
- Metastatic rate for cutaneous MST variable: 0%-24% with recurrence ± metastasis more likely for diffuse form
- Local tumor recurrence usually observed < 6 months
- Spontaneous regression is possible for histiocytic form and observation is appropriate
- Histopathologic grade has no prognostic significance
- Incomplete excision is not associated with a higher rate of local tumor recurrence
- Cutaneous MCT is not associated with metastatic disease [2.5% (4/160)] or death
- 12-month DFI 84%, 24-month DFI 65%, and 36-month DFI 52%
CLINICAL FEATURES
+ Diagnosis
- FNA of cutaneous mass: granules stain blue with Giemsa and purple with toluidine blue and appear more eosinophilic with hematoxylin and eosin stains
- Tissue biopsy and histology required for diagnosis of histiocytic MCT
- Disseminated disease: hematology, serum biochemistry, buffy coat smear, bone marrow aspirate, and coagulation profile
- Cats with systemic mastocytosis will have eosinophilia, basophilia and peripheral mastocytosis (50%)
- Mast cells can account for up to 25% of white blood cells in cats
- Coagulation abnormalities reported in 90% of cats with splenic MCT, but rarely clinically significant
- Methylated metabolites of histamine in urine may be a valuable diagnostic technique for mastocytosis
+ Treatment
- Surgery: resection for solitary cutaneous MCT, splenectomy for splenic MCT, and resection (5-10 cm margins recommended) with end-to-end anastomosis for intestinal MCT
- Wide surgical margins are not required for cutaneous MCT, unless diffuse form, due to their benign behaviour
- Effectiveness of adjunctive therapy unknown
- Combination chemotherapy protocols using prednisone, vincristine, cyclophosphamide, and methotrexate have not offered a survival advantage over surgery alone
+ Metastasis
2 forms of metastasis in feline MCT:
- Dermal and subcutis MCT metastasize to lymph node and viscera (i.e., similar to dog)
- MCT originates in hematopoietic cell precursors and disseminates throughout viscera